Pharmaceutical Care in Digital Revolution


Book Description

Pharmaceutical Care in the Digital Revolution: Blending Digital with Human Innovation, Second Edition provides readers with an updated view on how to use technology to improve pharmaceutical care (PC) and enhance drug outcomes with digital tools. Organized into four parts, including Global Healthcare Systems Under Pressure, Digital Advances to Innovate Pharmaceutical Care Journeys, Conditions to Drive Combinatoric Pharma-Digital Innovation, and What to do Tomorrow as a Pharmaceutical Care Leader, the book further examines digital developments that will optimize the PC process and prepare stakeholders for a dynamic future that will optimize the life of patients against a sustainable cost model. This edition also discusses recent advances in the digital health arena that will change the way we approach healthcare and prevention while also providing interactive links to lectures and technologies, tutorials on how to implement advances in your own working environment, and examples of pharmacists who are successful in building synergy between digital and pharma. - Teachers readers about new advances in digital health technology - Provides updated insights on future pharmaceutical care and how to implement essential conditions to create the best outlook for patients - Includes updated access links and QR codes as educational material for the book




Pharmaceutical Care in Digital Revolution


Book Description

Pharmaceutical Care in Digital Revolution demonstrates how blending human and digital pharmaceutical care can establish optimal Apothecary Intelligence (AI). Organized into four parts, it examines digital health advances that will synergize the pharmaceutical care process and prepares stakeholders for a dynamic future, fueled with innovation. Beginning with the global picture on health care systems, patients' expectations, and current pharmaceutical care practices, the book covers details of relevant digital technologies as well as compliance, ethical, educational, and cultural aspects to take successful steps towards digital pharmaceutical care. The text includes links to lectures and technology facts, tutorials on how to implement advances in your own working environment, and examples of stakeholders who are successful in building synergy between digital and pharma. Pharmaceutical Care in Digital Revolution is a practical resource to equip pharmaceutical care stakeholders, such as pharmacists, physicians, pharmacy technicians, and students as well as those in surrounding ecosystems like payers or regulators. It is a crucial reference to understand how technological innovation is changing the paradigm in which we provide current and future pharmaceutical care and how to keep it accessible, affordable, and sustainable. - Learn about advances in digital health technology and apply them as a change leader to create circular pharmaceutical care - Provides insights on future pharmaceutical care and implement essential conditions to create the best outlook for patients - Access links, QR codes, and explanatory animations as educational material to the book




The Creative Destruction of Medicine


Book Description

A professor of medicine reveals how technology like wireless internet, individual data, and personal genomics can be used to save lives.




The Fourth Industrial Revolution


Book Description

World-renowned economist Klaus Schwab, Founder and Executive Chairman of the World Economic Forum, explains that we have an opportunity to shape the fourth industrial revolu­tion, which will fundamentally alter how we live and work. Schwab argues that this revolution is different in scale, scope and complexity from any that have come before. Characterized by a range of new technologies that are fusing the physical, digital and biological worlds, the developments are affecting all disciplines, economies, industries and governments, and even challenging ideas about what it means to be human. Artificial intelligence is already all around us, from supercomputers, drones and virtual assistants to 3D printing, DNA sequencing, smart thermostats, wear­able sensors and microchips smaller than a grain of sand. But this is just the beginning: nanomaterials 200 times stronger than steel and a million times thinner than a strand of hair and the first transplant of a 3D printed liver are already in development. Imagine “smart factories” in which global systems of manu­facturing are coordinated virtually, or implantable mobile phones made of biosynthetic materials. The fourth industrial revolution, says Schwab, is more significant, and its ramifications more profound, than in any prior period of human history. He outlines the key technologies driving this revolution and discusses the major impacts expected on government, business, civil society and individu­als. Schwab also offers bold ideas on how to harness these changes and shape a better future—one in which technology empowers people rather than replaces them; progress serves society rather than disrupts it; and in which innovators respect moral and ethical boundaries rather than cross them. We all have the opportunity to contribute to developing new frame­works that advance progress.




Innovation in Pharmacy: Advances and Perspectives. September 2018


Book Description

This book contains the summaries of the "Innovation in Pharmacy: Advances and Perspectives" that took place in Salamanca (Spain) in September 2018. The early science of chemistry and microbiology were the source of most drugs until the revolution of genetic engineering in the mid 1970s. Then biotechnology made available novel protein agents such as interferons, blood factors and monoclonal antibodies that have changed the modern pharmacy. Over the past year, a new pharmacy of oligonucleotides has emerged from the science of gene expression such as RNA splicing and RNA interference. The ability to design therapeutic agents from genomic sequences will transform treatment for many diseases. The science that created this advance and its future promise will be discussed. Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for “the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence. He works in Institute Professor Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA, US. Este libro recoge los resúmenes de la «Innovation in Pharmacy: Advances and Perspectives» que tuvo lugar en Salamanca (España) en septiembre de 2018. La ciencia primitiva de la química y la microbiología fue la fuente de la mayoría de las drogas hasta la revolución de la ingeniería genética a mediados de la década de 1970. Luego, la biotecnología puso a disposición agentes proteínicos novedosos como interferones, factores sanguíneos y anticuerpos monoclonales que han cambiado la farmacia moderna. Durante el año pasado, surgió una nueva farmacia de oligonucleótidos a partir de la ciencia de la expresión génica, como el empalme de ARN y la interferencia de ARN. La capacidad de diseñar agentes terapéuticos a partir de secuencias genómicas transformará el tratamiento de muchas enfermedades. La ciencia que creó este avance y su promesa futura será discutida. Phillip Allen Sharp es un genetista y biólogo molecular estadounidense que co-descubrió el empalme de ARN. Compartió el Premio Nobel de 1993 en Fisiología o Medicina con Richard J. Roberts por "el descubrimiento de que los genes en eucariotas no son cadenas contiguas, sino que contienen intrones, y que el empalme del ARN mensajero para eliminar esos intrones puede ocurrir de diferentes maneras, produciendo diferentes proteínas de la misma secuencia de ADN. Trabaja en el Instituto Profesor Koch Institute for Integrative Cancer Research, Instituto Tecnológico de Massachusetts (MIT), Cambridge, MA, EE. UU.







The Second Information Revolution


Book Description

Thanks to inexpensive computers and data communications, the speed and volume of human communication are exponentially greater than they were even a quarter-century ago. Not since the advent of the telephone and telegraph in the nineteenth century has information technology changed daily life so radically. We are in the midst of what Gerald Brock calls a second information revolution. Brock traces the complex history of this revolution, from its roots in World War II through the bursting bubble of the Internet economy. As he explains, the revolution sprang from an interdependent series of technological advances, entrepreneurial innovations, and changes to public policy. Innovations in radar, computers, and electronic components for defense projects translated into rapid expansion in the private sector, but some opportunities were blocked by regulatory policies. The contentious political effort to accommodate new technology while protecting beneficiaries of the earlier regulated monopoly eventually resulted in a regulatory structure that facilitated the explosive growth in data communications. Brock synthesizes these complex factors into a readable economic history of the wholesale transformation of the way we exchange and process information. Table of Contents: Acknowledgments Abbreviations 1. Introduction The Promise of Regulation Conceptual Framework 2. The First Information Revolution The Development of Telegraph Services The Telephone and State Regulation Radio and Federal Regulation 3. Technological Origins of the Second Information Revolution, 1940-1950 Radar The Transistor Electronic Digital Computers 4. The SAGE Project I. THE SEPARATE WORLDS OF COMPUTERS AND COMMUNICATIONS, 1950-1968 5. The Early Semiconductor Industry The Creation of a Competitive Market Innovation and the Integrated Circuit Falling Prices, Rising Output 6. The Early Commercial Computer Industry Vacuum-Tube and Transistor Computers The System/360 and IBM Dominance Alternatives to IBM Computers 7. The Regulated Monopoly Telephone Industry Antitrust and the 1956 Consent Decree Microwave Technology and Potential Long Distance Competition Central Office Switches Terminal Equipment II. BOUNDARY DISPUTES AND LIMITED COMPETITION, 1969-1984 8. Data Communications Packet-Switching and the Arpanet Network Protocols and Interconnection Local Area Networks and Ethernet 9. From Mainframes to Microprocessors Intel and the Microprocessor Personal Computers and Workstations 10. The Computer-Communications Boundary Computer-Assisted Messages: Communications or Data Processing? Smart Terminals: Teletypewriters or Computers? Interconnection of Customer-Owned Equipment with the Telephone Network The Deregulation of Terminal Equipment The Deregulation of Enhanced Services 11. Fringe Competition in Long Distance Telephone Service Competition in Specialized Services Competition in Switched Services The Transition to Optical Fiber 12. Divestiture and Access Charges The Divestiture Access Charges The Enhanced Service Provider Exemption III. INTERCONNECTED COMPETITION AND INTEGRATED SERVICES, 1985-2002 13. Mobile Telephones and Spectrum Reform Early Land Mobile Telephones Cellular Spectrum Allocation Cellular Licensing Problems Spectrum Institutional Reform PCS and Auctions 14. Local Competition and the Telecommunications Act of 1996 Competitive Access Providers Interconnection: CAP to CLEC The Telecommunications Act of 1996 Implementation of the Telecommunications Act of 1996 15. The Internet and the World Wide Web The Commercial Internet and Backbone Interconnection The Development of the Web The New Economy Financial Boom and Bust Real Growth in Telecommunication and Price Benefits 16. Conclusion Technological Progress and Policy Evolution The Process of Institutional Change Final Comment References Index Reviews of this book: The Second Information Revolution is important reading for anyone who needs to understand the functioning of American telecommunications, either to be able to analyse today's financial markets or to understand or influence public policy in this area. --Wendy M. Grossman, Times Higher Education Supplement [UK] Reviews of this book: Brock traces a phenomenon he refers to as the 'second information revolution.' According to Brock, there have been two times in history when information technology has dramatically changed daily life. The first 'information revolution' occurred with the advent of the telephone and telegraph, which made communication less expensive and more readily available. The second information revolution is currently in progress...A concise, thorough, and well-written history of the transformation in exchanging and processing of information. --K. A. Coombs, Choice




Ten Drugs


Book Description

“The stories are skillfully told and entirely entertaining . . . An expert, mostly feel-good book about modern medicine” from the award-winning author (Kirkus Reviews, starred review). Behind every landmark drug is a story. It could be an oddball researcher’s genius insight, a catalyzing moment in geopolitical history, a new breakthrough technology, or an unexpected but welcome side effect discovered during clinical trials. Piece together these stories, as Thomas Hager does in this remarkable, century-spanning history, and you can trace the evolution of our culture and the practice of medicine. Beginning with opium, the “joy plant,” which has been used for 10,000 years, Hager tells a captivating story of medicine. His subjects include the largely forgotten female pioneer who introduced smallpox inoculation to Britain, the infamous knockout drops, the first antibiotic, which saved countless lives, the first antipsychotic, which helped empty public mental hospitals, Viagra, statins, and the new frontier of monoclonal antibodies. This is a deep, wide-ranging, and wildly entertaining book. “[An] absorbing new book.” —The New York Times Book Review “[A] well-written and engaging chronicle.” —The Wall Street Journal “Lucidly informative and compulsively readable.” —Publishers Weekly “Entertaining [and] insightful.” —Booklist “Well-written, well-researched and fascinating to read Ten Drugs provides an insightful look at how drugs have shaped modern medical practices. Towards the end of the book Hager writes that he ‘came away surprised by some of the things he had learned.’ I had the very same reaction.” —Penny Le Couteur, coauthor of Napoleon’s Buttons: How 17 Molecules Changed History




Emergence of Pharmaceutical Industry Growth with Industrial IoT Approach


Book Description

Emergence of Pharmaceutical Industry Growth with Industrial IoT Approach uses an innovative approach to explore how the Internet of Things (IoT) and big data can improve approaches, create efficiencies and make discoveries. Rapid growth of the IoT has encouraged many companies in the manufacturing sector to make use of this technology to unlock its potential. Pharmaceutical manufacturing companies are no exception to this, as IoT has the potential to revolutionize aspects of the pharmaceutical manufacturing process, from drug discovery to manufacturing. Using clear, concise language and real world case studies, this book discusses systems level from both a human-factors point-of-view and the perspective of networking, databases, privacy and anti-spoofing. The wide variety of topics presented offers readers multiple perspectives on a how to integrate the Internet of Things into pharmaceutical manufacturing. - Covers efficiency improvements of pharmaceutical manufacturing through IoT/Big Data approaches - Explores cutting-edge technologies through sensor enabled environment in the pharmaceutical industry - Discusses the systems level from both a human-factors point-of-view and the perspective of networking, databases, privacy and anti-spoofing




Responsible Innovation in Digital Health


Book Description

Powerful new approaches and advances in medical systems drive increasingly high expectations for healthcare providers internationally. The form of digital healthcare – a suite of new technologies offering significant benefits in cost and quality – allow institutions to keep pace with society’s needs. This book covers the need for responsible innovation in this area, exploring the issues of implementation as well as potential negative consequences to ensure digital healthcare delivers for the benefit of all stakeholders.